RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation
Joachim Schwäble(Goethe University Frankfurt), Hubert Serve(Goethe University Frankfurt)
Cited by 75
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
|Molecular Cell|2009|315
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
|Blood|2017|300
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|185